JPH0394777A - Medical treatment device - Google Patents
Medical treatment deviceInfo
- Publication number
- JPH0394777A JPH0394777A JP1231403A JP23140389A JPH0394777A JP H0394777 A JPH0394777 A JP H0394777A JP 1231403 A JP1231403 A JP 1231403A JP 23140389 A JP23140389 A JP 23140389A JP H0394777 A JPH0394777 A JP H0394777A
- Authority
- JP
- Japan
- Prior art keywords
- balloon
- light
- medical treatment
- semiconductor electrode
- semiconductor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004065 semiconductor Substances 0.000 claims abstract description 43
- 239000000126 substance Substances 0.000 claims abstract 2
- 238000003780 insertion Methods 0.000 claims description 26
- 230000037431 insertion Effects 0.000 claims description 26
- 230000001699 photocatalysis Effects 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 8
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000012780 transparent material Substances 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 abstract description 20
- 239000000835 fiber Substances 0.000 abstract description 16
- 206010028980 Neoplasm Diseases 0.000 abstract description 15
- 238000007254 oxidation reaction Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000002093 peripheral effect Effects 0.000 abstract description 5
- 230000003287 optical effect Effects 0.000 abstract description 3
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 230000008520 organization Effects 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 18
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 11
- 239000010419 fine particle Substances 0.000 description 9
- 238000005286 illumination Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 5
- 239000004020 conductor Substances 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 101100481408 Danio rerio tie2 gene Proteins 0.000 description 2
- 101100481410 Mus musculus Tek gene Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001443 photoexcitation Effects 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Surgical Instruments (AREA)
- Laser Surgery Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、生体内に挿入して生体の患部を治療するため
の治療装置に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a treatment device that is inserted into a living body to treat an affected part of the living body.
[従来の技術J
最近では癌などの悪性腫瘍を治療する方法として光電気
化学治療が知られている。これは光励起された半導体表
面が有する強い反応性を、癌細胞の殺細胞効果に応用し
たもので、癌細胞を死滅させるに顕著な効果があること
が実験により明らかになっている。[Prior Art J] Recently, photoelectrochemical therapy has been known as a method for treating malignant tumors such as cancer. This is an application of the strong reactivity of the photo-excited semiconductor surface to the killing effect on cancer cells, and experiments have shown that it has a remarkable effect on killing cancer cells.
ここで、半導体微粒子の光化学反応の原理について説明
すると、第10図に示すように、ある種の半導体は、光
を当てると光励起により価電子帯の電子が伝導体に励起
され、価電子帯に正孔ができる。この電子と正孔が再結
合しなければ、これらを酸化還元反応に利用できる。す
なわち、伝導体に励起された電子は価電子帯の電子より
バンドギャップ分だけエネルギーが高いため還元力が強
く、価電子帯の正孔は伝導体の空準位よりバンドギャッ
プ分だけ電子親和力が大きいので酸化能力がある。酸化
力、還元力ともに強い半導体として酸化チタン(以下、
TLO2という)が知られており、このTie,の半導
体微粒子に白金(以下、Ptという)を担持すると、T
i02の光触媒能が著しく増加することも知られている
。ptを含むTiO2の粉末が溶液に懸濁している状態
の光触媒系は、光化学電池同様、半導体が光励起される
ことによっていろいろの反応が進行する。この光励起は
半導体のバンドギャップに相当する波長?りも短波長(
T i 02の場合415nm)の光が照射されると起
こり、光励起されたTiO■表面は非常に強い酸化力を
有し、いろいろ化合物を酸化分解できる。Here, to explain the principle of photochemical reaction of semiconductor particles, as shown in Figure 10, when some types of semiconductors are exposed to light, electrons in the valence band are excited into the conductor by photoexcitation, and the electrons in the valence band are excited. A hole is created. If these electrons and holes do not recombine, they can be used for redox reactions. In other words, electrons excited in a conductor have higher energy than electrons in the valence band by the amount of the band gap, so they have a stronger reducing power, and holes in the valence band have a higher electron affinity than empty levels in the conductor by the amount of the band gap. Because it is large, it has oxidizing ability. Titanium oxide (hereinafter referred to as
TLO2) is known, and when platinum (hereinafter referred to as Pt) is supported on semiconductor fine particles of this Tie, TLO2 is known.
It is also known that the photocatalytic ability of i02 is significantly increased. In a photocatalytic system in which TiO2 powder containing pt is suspended in a solution, various reactions proceed as a semiconductor is photoexcited, similar to a photochemical cell. Is this optical excitation at a wavelength corresponding to the semiconductor bandgap? Rimo short wavelength (
This occurs when light of 415 nm (in the case of T i 02) is irradiated, and the photoexcited TiO2 surface has a very strong oxidizing power and can oxidize and decompose various compounds.
また、半導体微粒子の粒径が小さい程、反応活性度は大
きくなる( T i O 2の場合、0.2μm以下が
反応活性度最大)とともに、半導体微粒子の数が多い程
、また光量が大きい程効果が大きい。In addition, the smaller the particle size of the semiconductor fine particles, the higher the reaction activity (in the case of TiO2, the maximum reaction activity is 0.2 μm or less), and the larger the number of semiconductor fine particles and the greater the amount of light. Great effect.
この半導体が光励起されることによる反応を利用して殺
菌、悪性腫瘍等の死滅させる技術は、例えば特開昭62
−87526号公報、特開昭63− 1. 7 7 8
4 9号公報において公知であり、特に後者のものは
、内視鏡の挿通チャンネルを通じて治療用ブローブを生
体に導入し、光触媒効果を有する半導体電極と白金電極
を癌部位に穿刺し、前記治療用プローブの先端面から照
射されるレーザ光を前記半導体電極の表面に照射するよ
うになっている。半導体電極にレーザ光が照射されると
、半導体電極上では酸化反応が起こり、白金電極上では
還元反応が起こる。そして、両電極間には癌部位がある
ことにより、水分成分に前記反応が起こり、半導体電極
上では酸素が発生し、白金電極上では水分が発生し、つ
まり、光触媒効果が生じることになる。For example, the technology for sterilizing and killing malignant tumors by utilizing the reaction caused by photoexcitation of semiconductors was developed in Japanese Patent Application Laid-open No. 62
Publication No. 87526, JP-A-63-1. 7 7 8
49, particularly the latter, a therapeutic probe is introduced into a living body through an insertion channel of an endoscope, a semiconductor electrode and a platinum electrode having a photocatalytic effect are punctured into a cancer site, and the therapeutic probe is introduced into a living body through an insertion channel of an endoscope. The surface of the semiconductor electrode is irradiated with laser light emitted from the tip surface of the probe. When the semiconductor electrode is irradiated with laser light, an oxidation reaction occurs on the semiconductor electrode, and a reduction reaction occurs on the platinum electrode. Since there is a cancerous site between the two electrodes, the reaction occurs in the moisture component, and oxygen is generated on the semiconductor electrode and moisture is generated on the platinum electrode, that is, a photocatalytic effect occurs.
[発明が解決しようとする課題]
しかしながら、前述のような治療装置は、内視鏡の挿通
チャンネルを通じて治療用ブローブを生体に導入し、光
触媒効果を有する半導体電極と白金電極を癌組織等の目
的部位に穿刺するものであり、局部的な治療となるとと
もに、患部形状によっては治療が困難で、人体における
治療部位が限定されるという問題がある。[Problems to be Solved by the Invention] However, the above-mentioned treatment device introduces a therapeutic probe into a living body through an insertion channel of an endoscope, and uses a semiconductor electrode and a platinum electrode that have a photocatalytic effect to target cancer tissue or the like. The problem is that the treatment is localized, and treatment is difficult depending on the shape of the affected area, which limits the treatment area in the human body.
本発明は上記課題に着目してなされたもので、その目的
とするところは、患部形状が護雑であっても、確実に治
療でき、また、一度に面積の広い患部を治療できる治療
装置を提供することにある。The present invention has been made in view of the above problems, and its purpose is to provide a treatment device that can reliably treat even if the shape of the affected area is rough, and that can treat a large area of the affected area at one time. It is about providing.
[課題を解決するための手段および作用コ前記課題を解
決するために本発明の治療装置は、生体内に挿入される
挿入部に膨脹・収縮可能な透明部材からなるバルーンを
設け、このバルーンの外表面に光触媒効果を有する半導
体物質を設ける一方、前記挿入部に前記バルーンに光照
射する導光手段を設ける。[Means and Effects for Solving the Problems] In order to solve the above problems, the treatment device of the present invention includes a balloon made of an inflatable and deflated transparent member in an insertion section inserted into a living body, and a balloon made of an inflatable and deflated transparent member. A semiconductor material having a photocatalytic effect is provided on the outer surface, and a light guiding means for irradiating the balloon with light is provided in the insertion portion.
挿入部を生体に挿入してバルーンを患部に接触させ、こ
のバルーンの内側から半導体物質に向けて光を照射する
と、半導体物質が酸化反応を起こして悪性腫瘍を死滅さ
せる。When the insertion part is inserted into a living body and the balloon is brought into contact with the affected area, and light is irradiated from inside the balloon toward the semiconductor material, the semiconductor material undergoes an oxidation reaction and kills the malignant tumor.
[実施例コ 以下、本発明の各実施例を図面に基づいて説明する。[Example code] Hereinafter, each embodiment of the present invention will be described based on the drawings.
第1図〜第5図は第1の実施例を示すものである。第1
図は治療装置1の全体を示し、2は体腔内に挿入される
挿入部である。挿入部2は可撓性を有するチューブによ
って形成され、内部には第2図に示すように、軸方向に
送気管路3が設けられている。挿入部2の先端部には膨
脹・収縮可能なシリコーン等の透明部材からなるバルー
ン4が設けられている。挿入部2の基端部には接続管体
5が設けられ、この接続管体5は前記送気管路3に通じ
る送気チューブ6を介して送気シリンジ7に連通してい
る。また、前記挿入部2の送気青ア:13には光照射す
る導光子段としての導光ファイバ8が挿入されており、
この先端部は前記ハル−74の内部に対向し、基端部は
光源装置9に接続されている。1 to 5 show a first embodiment. 1st
The figure shows the entire treatment device 1, and 2 is an insertion portion inserted into a body cavity. The insertion section 2 is formed of a flexible tube, and as shown in FIG. 2, an air supply line 3 is provided in the axial direction. A balloon 4 made of a transparent material such as silicone that can be expanded and contracted is provided at the distal end of the insertion section 2. A connecting tube body 5 is provided at the base end of the insertion section 2, and this connecting tube body 5 communicates with an air supply syringe 7 via an air tube 6 communicating with the air supply conduit 3. Further, a light guide fiber 8 as a light guide stage for irradiating light is inserted into the air supply blue A: 13 of the insertion section 2,
The distal end faces the inside of the hull 74, and the proximal end is connected to the light source device 9.
前記バルーン4の外表面には第3図に示すように、光触
媒効果を有する半導体物質としてのTi02からなる半
導体電極10・・・が設けられている。この半導体電極
10は、バルーン4のディビング製造工程後、その表面
にTiO2微粒子を吹き付けて付着させたものであり、
第4図に示すように、バルーン4の表面に半導体8極1
0が一体的に固着されている。As shown in FIG. 3, the outer surface of the balloon 4 is provided with semiconductor electrodes 10 made of TiO2 as a semiconductor material having a photocatalytic effect. This semiconductor electrode 10 is made by spraying and adhering TiO2 fine particles onto the surface of the balloon 4 after the dipping manufacturing process.
As shown in FIG.
0 is integrally fixed.
第3図は治療装置1の使用例を示し、体腔内11に発生
した悪性腫瘍、例えば癌組織12にバルーン4を接触し
た状態を示す。すなわち、送気シリンジ7によって送気
すると、送気管路3を介してバルーン4に送気され、バ
ルーン4が膨脹する。そして、バルーン4の外表面に付
着された半導体電極10・・・が癌組織12に接触した
状態にある。FIG. 3 shows an example of the use of the treatment device 1, in which the balloon 4 is brought into contact with a malignant tumor, for example, a cancerous tissue 12, which has developed in a body cavity 11. That is, when air is supplied by the air supply syringe 7, air is supplied to the balloon 4 through the air supply pipe line 3, and the balloon 4 is inflated. The semiconductor electrodes 10 attached to the outer surface of the balloon 4 are in contact with the cancerous tissue 12.
この状態において、柿八部2の送気管路3に導光ファイ
バ8を挿入し、光源装置9から出射された光をバルーン
4の内周面に向って導光すると、照明光は透明部材であ
るバルーン4の周壁を透過して半導体電極10に届く。In this state, when the light guide fiber 8 is inserted into the air supply pipe 3 of the Kakihachi section 2 and the light emitted from the light source device 9 is guided toward the inner peripheral surface of the balloon 4, the illumination light is transmitted through the transparent member. The light passes through the peripheral wall of a certain balloon 4 and reaches the semiconductor electrode 10.
半導体電極10に照明光が当たると、半導体電極10上
では酸化反応が起こり、光触媒効果によって癌組織12
を死滅させることができる。この場合、癌組織12が広
範囲であってもバルーン4が癌組織12の全面を覆う状
態となるため、一度に広範囲に亘る治療ができ、また、
バルーン4は弾性変形するため、患部の形状に倣って密
着し、患部形状が複雑であっても治療できる。When the semiconductor electrode 10 is irradiated with illumination light, an oxidation reaction occurs on the semiconductor electrode 10, and cancer tissue 12 is removed by the photocatalytic effect.
can be killed. In this case, even if the cancerous tissue 12 is spread over a wide area, the balloon 4 will cover the entire surface of the cancerous tissue 12, so that a wide area can be treated at once, and
Since the balloon 4 is elastically deformed, it closely follows the shape of the affected area and can be treated even if the affected area has a complicated shape.
なお、バルーン4に半導体電極10を付着する手段とし
てディビング製造工程後、その表面にTie2微粒子を
吹き付けて付着させたが、デイビング用材料中にTiO
2微粒子を混入させておいてもよい。さらに、第5図に
示すように、光触媒効果を有するTi02の半導体電極
10にpt微粒子からなる金属13を担持してもよい。Note that as a means of attaching the semiconductor electrode 10 to the balloon 4, Tie2 fine particles were sprayed onto the surface of the balloon after the diving manufacturing process, but TiO
2. Fine particles may be mixed. Further, as shown in FIG. 5, a metal 13 made of PT fine particles may be supported on a Ti02 semiconductor electrode 10 having a photocatalytic effect.
Tie2にptを担持すると、TiO2の光触媒能が著
しく増加し、癌組織12を効果的に死滅させることがで
きる。When Tie2 carries pt, the photocatalytic ability of TiO2 increases significantly, and cancer tissue 12 can be effectively killed.
また、導光手段としては光源装置9からの照明光に限定
されず、レーザ光を照射してもよい。なお、レーザは、
410nmより短波長のもの、例えばエキシマレーザ、
エキシマDycレーザ、クリブトンレーザ等の紫外域レ
ーザ等が好ましい。Furthermore, the light guiding means is not limited to the illumination light from the light source device 9, and may also be irradiated with laser light. In addition, the laser is
Those with wavelengths shorter than 410 nm, such as excimer lasers,
Ultraviolet lasers such as excimer Dyc lasers and Crybton lasers are preferred.
第6図は第2の実施例を示すもので、直視型内視鏡14
の挿入部15における先端部16に第1の実施例と同様
のバルーン4を設けたものである。FIG. 6 shows a second embodiment, in which a direct viewing endoscope 14
A balloon 4 similar to that of the first embodiment is provided at the distal end 16 of the insertion section 15.
挿入部15にはイメージガイドファイバー1.6、ライ
トガイドファイバー17等が内装されている。An image guide fiber 1.6, a light guide fiber 17, etc. are installed inside the insertion section 15.
したがって、体腔内11に発生した癌組織12にバルー
ン4を接触し、癌組織12をバルーン4を介してイメー
ジガイドファイバー16により観察でき、ライトガイド
ファイバー17から出射する照明光が半導体71S極1
0に当たると、半導体電極10上では酸化反応が起こり
、先触媒効果によつて癌紹織12を死滅させることがで
きる。つまり、癌絹織12を観察しながら治療すること
ができる。Therefore, the balloon 4 is brought into contact with the cancerous tissue 12 generated in the body cavity 11, and the cancerous tissue 12 can be observed by the image guide fiber 16 through the balloon 4, and the illumination light emitted from the light guide fiber 17 is transmitted to the semiconductor 71S pole 1.
When the temperature reaches 0, an oxidation reaction occurs on the semiconductor electrode 10, and the cancer tissue 12 can be killed by the pre-catalytic effect. In other words, the cancer silk fabric 12 can be treated while being observed.
第7図は第3の実施例を示すもので、可撓性チューブか
らなる神大部18の先端部1つにおける側部に開口部2
0が設けられている。この開口部20には開口を塞ぐよ
うに、実質的に第1の実施例と同様のバルーン4が設け
られている。挿入部18の内部には送気管路21が設け
られ、この送気管路21には導光ファイバ22が挿入さ
れている。したがって、体腔23の下面から隆起した患
部24の場含には患部24がバルーン4を押圧し、患部
24とバルーン4とが密着する。この状態で、導光ファ
イバ22から照明光を出射すると、前記実施例と同様に
半導体電極10上では酸化反応が起こり、光触媒効果に
よって患部24を治療することができる。FIG. 7 shows a third embodiment, in which an opening 2 is formed on the side of one tip of a flexible tube 18.
0 is set. A balloon 4 substantially similar to that of the first embodiment is provided in this opening 20 so as to close the opening. An air supply conduit 21 is provided inside the insertion portion 18, and a light guide fiber 22 is inserted into this air supply conduit 21. Therefore, the affected area 24 presses the balloon 4 in the area where the affected area 24 protrudes from the lower surface of the body cavity 23, and the affected area 24 and the balloon 4 come into close contact. In this state, when illumination light is emitted from the light guide fiber 22, an oxidation reaction occurs on the semiconductor electrode 10 as in the previous embodiment, and the affected area 24 can be treated by the photocatalytic effect.
第8図は第4の実施例を示すもので、可撓性チューブか
らなる神人部25には導光ファイバ26と送気管路27
が設けられている。挿入部25の先端部28には前記導
光ファイバ26と拮合する透明ゴム29が設けられ、さ
らに先端部28には透明ゴム29を囲繞するように、実
質的に第1の実施例と同様のバルーン30が設けられて
いる。FIG. 8 shows a fourth embodiment, in which a light guiding fiber 26 and an air supply pipe 27 are provided in a divine part 25 made of a flexible tube.
is provided. A transparent rubber 29 is provided at the distal end 28 of the insertion portion 25 to match with the light guide fiber 26, and the distal end 28 is provided with a transparent rubber 29 so as to surround the transparent rubber 29, substantially the same as in the first embodiment. A balloon 30 is provided.
したがって、管腔31の内周面に発生した癌組織32の
場合には管腔31の内部に挿入部25を押入した状態で
、バルーン30を膨脹させると、ハルーン30が癌組織
32に密着する。この状態で、導光ファイバ26から照
明光を出射すると、前記実施例と同様に半導体電極10
上では酸化反応が起こり、光触媒効果によって癌組織3
2を治療することができる。Therefore, in the case of cancer tissue 32 that has developed on the inner peripheral surface of the lumen 31, when the balloon 30 is inflated with the insertion portion 25 pushed into the interior of the lumen 31, the balloon 30 comes into close contact with the cancer tissue 32. . In this state, when illumination light is emitted from the light guide fiber 26, the semiconductor electrode 10
An oxidation reaction occurs above the cancer tissue 3 due to the photocatalytic effect.
2 can be treated.
第9図は第5の実施例を示すもので、33は内視鏡34
の挿入部であり、先端部にはccDlの固体撮像素子3
5、ドライブ回路36が設けられている。さらに、挿入
部33には挿通チャンネル37が設けられ、この挿通チ
ャンネル37に治療装置としてのブローブ38が挿入さ
れている。ブローブ38には導光ファイバ39と送気管
路(図示しない)が内装され、このプローブ38の先端
部40には前記導光ファイバ3つの出躬面に対向するミ
ラー41が設けられている。さらに、前記先端部40に
は実質的に第1の実施例と同様のバルーン42が設けら
れている。FIG. 9 shows a fifth embodiment, and 33 is an endoscope 34.
It is an insertion part, and the tip part has a ccDl solid-state image sensor 3.
5. A drive circuit 36 is provided. Further, the insertion section 33 is provided with an insertion channel 37, into which a probe 38 as a treatment device is inserted. The probe 38 is equipped with a light guide fiber 39 and an air supply line (not shown), and a mirror 41 is provided at the tip 40 of the probe 38, facing the exit surface of the three light guide fibers. Further, the distal end portion 40 is provided with a balloon 42 substantially similar to the first embodiment.
したがって、体腔43の下面に発生した癌組織44の場
合には体腔43の内部に挿入部33を挿入した状態で、
バルーン42を膨脹させると、バルーン42が癌組織4
4に密着する。この状態で、導光ファイバ3つから照明
光を出射すると、前記実施例と同様に半導体電極10上
では酸化反応が起こり、光触媒効果によって癌組織44
を治療することができる。Therefore, in the case of cancerous tissue 44 that has developed on the lower surface of the body cavity 43, with the insertion section 33 inserted inside the body cavity 43,
When the balloon 42 is inflated, the balloon 42 expands into the cancerous tissue 4.
Closely attached to 4. In this state, when illumination light is emitted from the three light guide fibers, an oxidation reaction occurs on the semiconductor electrode 10 as in the previous embodiment, and the photocatalytic effect causes cancer tissue 44.
can be treated.
[発明の効果]
以上説明したように本発明によれば、生体内に挿入され
る挿入部に膨脹・収縮可能な透明部材からなるバルーン
を設け、このバルーンの外表面に光触媒効果を有する半
導体物質を設ける一方、前記挿入部に前記バルーンに光
照射する導光手段を設けたから、半導体物質に向けて光
を照射すると、半導体物質が酸化反応を起こして悪性腫
瘍を死滅させる患部形状が複雑であっても、確実に治療
でき、また、一度に面積の広い患部を治療できる治療装
置を提供できる。[Effects of the Invention] As explained above, according to the present invention, a balloon made of an inflatable and deflated transparent member is provided in the insertion portion inserted into a living body, and a semiconductor material having a photocatalytic effect is coated on the outer surface of the balloon. On the other hand, since a light guiding means for irradiating the balloon with light is provided in the insertion part, when the light is irradiated toward the semiconductor material, the semiconductor material causes an oxidation reaction and the malignant tumor is killed. Therefore, it is possible to provide a treatment device that can reliably treat even the most affected areas, and can treat a wide area of affected areas at once.
第1図〜第5図は本発明の第1の実施例を示し、第1図
は治療装置の側面図、第2図はその使用状態の縦断面図
、第3図はバルーンの一部を拡大した断面図、第4図は
TiO2微粒子の拡大した断面図、第5図はptを担持
したT i 0 2微粒子の拡大した断面図、第6図は
本発明の第2の実施例を示す治療装置の使用状態の断面
図、第7図は本発明の第3の実施例を示す治療装置の使
用状態の断面図、第8図は本発明の第4の実施例を示す
治療装置の使用状態の断面図、第9図は本発明の第5の
実施例を示す治療装置の使用状態の断面図、第10図は
光電気化学反応プロセスを示す図である。
1・・・治療装置、2・・・挿入部、4・・・バルーン
、8・・・導光ファイバ、10・・・半導体電極。1 to 5 show a first embodiment of the present invention, FIG. 1 is a side view of the treatment device, FIG. 2 is a longitudinal sectional view of the device in use, and FIG. 3 shows a part of the balloon. FIG. 4 shows an enlarged cross-sectional view of TiO2 fine particles, FIG. 5 shows an enlarged cross-sectional view of TiO2 fine particles carrying PT, and FIG. 6 shows a second embodiment of the present invention. 7 is a cross-sectional view of the treatment device in use, showing a third embodiment of the present invention; FIG. 8 is a cross-sectional view of the treatment device in use, showing a fourth embodiment of the present invention. FIG. 9 is a cross-sectional view of the treatment device in use according to the fifth embodiment of the present invention, and FIG. 10 is a diagram showing a photoelectrochemical reaction process. DESCRIPTION OF SYMBOLS 1... Treatment device, 2... Insertion part, 4... Balloon, 8... Light guide fiber, 10... Semiconductor electrode.
Claims (1)
脹・収縮可能な透明部材からなるバルーンと、このバル
ーンの外表面に設けた光触媒効果を有する半導体物質と
、前記挿入部に設けられ前記バルーンに光照射する導光
手段とを具備したことを特徴とする治療装置。An insertion section inserted into a living body, a balloon made of an inflatable and deflated transparent member provided in the insertion section, a semiconductor material having a photocatalytic effect provided on the outer surface of the balloon, and a semiconductor substance provided in the insertion section made of a transparent material that can be expanded and contracted. A treatment device comprising: a light guiding means for irradiating light onto the balloon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1231403A JPH0394777A (en) | 1989-09-08 | 1989-09-08 | Medical treatment device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1231403A JPH0394777A (en) | 1989-09-08 | 1989-09-08 | Medical treatment device |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0394777A true JPH0394777A (en) | 1991-04-19 |
Family
ID=16923058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1231403A Pending JPH0394777A (en) | 1989-09-08 | 1989-09-08 | Medical treatment device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0394777A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009160446A (en) * | 2009-04-21 | 2009-07-23 | Kawasumi Lab Inc | Inducing catheter of laser fiber |
JP2022553301A (en) * | 2019-10-21 | 2022-12-22 | インキャンド セラピューティクス プライベート リミテッド | Method and apparatus for phototherapy |
-
1989
- 1989-09-08 JP JP1231403A patent/JPH0394777A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009160446A (en) * | 2009-04-21 | 2009-07-23 | Kawasumi Lab Inc | Inducing catheter of laser fiber |
JP2022553301A (en) * | 2019-10-21 | 2022-12-22 | インキャンド セラピューティクス プライベート リミテッド | Method and apparatus for phototherapy |
US11957929B2 (en) | 2019-10-21 | 2024-04-16 | Incando Therapeutics Pte. Ltd. | Methods and apparatus for phototherapy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3648555B2 (en) | Improved phototherapy device for irradiating a columnar environment | |
JP4122323B2 (en) | Balloon catheter for photodynamic therapy | |
EP0266038B1 (en) | Apparatus for treatment of cancer with photodiode | |
US6860879B2 (en) | Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and/or photodynamic therapy | |
JP3170313U (en) | Device for photodynamic therapy of biological tissue | |
EP1663393A1 (en) | Near infrared microbial elimination laser system | |
JPH0394777A (en) | Medical treatment device | |
JPH0394778A (en) | Medical treatment device | |
JPH0394759A (en) | Treating implement sterilizing system for endoscope | |
JPH0394762A (en) | Tubular member for living body | |
JPH0394780A (en) | Treating device | |
JP4309040B2 (en) | Optical fiber, dental laser treatment apparatus having the optical fiber mounted thereon, manufacturing method thereof, and usage method thereof | |
RU2595792C2 (en) | Device for use in antimicrobial photodynamic therapy | |
TWI841181B (en) | Catheter set and system for site-directed release of therapeutic gas | |
JPH03261467A (en) | Cancer treating device | |
US20190232084A1 (en) | Device for feeding a line through the skin of a patient | |
JP4375843B2 (en) | Contact tip | |
JP2572678Y2 (en) | Insertion needle for laser beam therapy equipment | |
JPH10127789A (en) | Light beam processing device | |
JPH0349681Y2 (en) | ||
JPH03176075A (en) | Apparatus for releasing medicine gradually | |
JPH0449957A (en) | Laser irradiator for endoscope | |
KR20230094350A (en) | Citric Acid Solution Spraying Device | |
JPS6260571A (en) | Fiber applicator for endoscopic treatment | |
JPH09266955A (en) | Laser therapy method for organism tissue and target used therefor |